Discontinuation report RAN-GABAPENTIN

Last updated on 2019-03-29 History
Report ID 80051
Drug Identification Number 02319071
Brand name RAN-GABAPENTIN
Common or Proper name RAN-GABAPENTIN
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status CANCELLED POST MARKET
Active Ingredient(s) GABAPENTIN
Strength(s) 400MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 & 500
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-12-04
Remaining supply date 2018-12-04
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments 300 mg remains available
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-03-29 French Compare
v1 2019-03-29 English Compare

Showing 1 to 2 of 2